5-amino-1mq clinical trials Vial 5 Amino-1MQ 5mg

Carter, R., Mouralidarane, A., Ray, S., Soeda, J

Study 5: Phase 2b clinical study, failure in obesity Citation: Metabolic Pharmaceuticals Phase 2b trial (2007), not fully published

Compared to full-length HGH: No effects on blood glucose or insulin sensitivity No risk of acromegaly or excessive tissue growth No joint pain or carpal tunnel syndrome No edema or fluid retention A considerably safer metabolic profile Compared to stimulant-based fat-loss compounds: No cardiovascular stimulation No effects on blood pressure or heart rate No anxiety or jitteriness No sleep disturbances A much better cardiovascular safety profile Compared to other peptides: Similar safety to other well-tolerated peptides Fewer systemic effects than GH secretagogues No hormonal disruption Minimal drug interactions Contraindications and Precautions Certain conditions warrant extra caution or exclusion from research

Benefits of 5-Amino-1MQ may include: Non stimulant treatment that supports fat loss Targets excess body fat Can treat related metabolic conditions (i.e

doi: 10.1016/0196-9781(89)90065-x 122 Sackmann-SalaLDingJFrohmanLAKopchickJJ

Most research protocols specify fasted administration with a 3060 minute wait before eating